BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells

• Nam-Hee Kim,

  Affiliations Division of Genome Medicine, Institute for Genome Research, Tokushima University, Tokushima, Japan, Department of Orthodontics and Dentofacial Orthopedics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

  ⨯
• Tetsuro Yoshimaru,

  Affiliation Division of Genome Medicine, Institute for Genome Research, Tokushima University, Tokushima, Japan

  ⨯
• Yi-An Chen,

  Affiliation National Institute of Biomedical Innovation, Osaka, Japan

  ⨯
• Taisuke Matsuo,

  Current address: Department of Advanced Pharmaceutics, School of Pharmacy, Iwate Medical University, Iwate, Japan

  Affiliation Division of Genome Medicine, Institute for Genome Research, Tokushima University, Tokushima, Japan

  ⨯
• Masato Komatsu,

  Affiliation Division of Genome Medicine, Institute for Genome Research, Tokushima University, Tokushima, Japan

  ⨯
• Yasuo Miyoshi,

  Affiliation Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Hyogo, Japan

  ⨯
• Eiji Tanaka,

  Affiliation Department of Orthodontics and Dentofacial Orthopedics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

  ⨯
• Mitsunori Sasa,

  Affiliation Department of Surgery, Tokushima Breast Care Clinic, Tokushima, Japan

  ⨯
• Kenji Mizuguchi,

  Affiliation National Institute of Biomedical Innovation, Osaka, Japan

  ⨯
• Toyomasa Katagiri

  * E-mail: tkatagi@genome.tokushima-u.ac.jp

  Affiliation Division of Genome Medicine, Institute for Genome Research, Tokushima University, Tokushima, Japan

  ⨯